CN110538346A - preparation method of porous nano hydroxyapatite sustained-release gel - Google Patents
preparation method of porous nano hydroxyapatite sustained-release gel Download PDFInfo
- Publication number
- CN110538346A CN110538346A CN201910323669.7A CN201910323669A CN110538346A CN 110538346 A CN110538346 A CN 110538346A CN 201910323669 A CN201910323669 A CN 201910323669A CN 110538346 A CN110538346 A CN 110538346A
- Authority
- CN
- China
- Prior art keywords
- porous nano
- hydroxyapatite
- nano hydroxyapatite
- release gel
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/12—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/58—Materials at least partially resorbable by the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/602—Type of release, e.g. controlled, sustained, slow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/12—Nanosized materials, e.g. nanofibres, nanoparticles, nanowires, nanotubes; Nanostructured surfaces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/12—Materials or treatment for tissue regeneration for dental implants or prostheses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Dermatology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
Abstract
the invention provides a preparation method of porous nano hydroxyapatite sustained release gel. The hydroxyapatite composite microsphere prepared by the method has uniform size distribution, the particle size distribution range of 10-100 mu m and the central particle size of 20-60 mu m. The organic phase is added in the mixing process, so that the suspension stability of the suspension can be effectively enhanced, the prepared microspheres are uniform in size distribution, have larger particle size than the microspheres prepared by the traditional spray drying method, and can be used as an inner support material of an injection; the microsphere has good sphericity, high porosity, enhanced injectability, accelerated drug metabolism, stable and effective drug concentration, and good drug release.
Description
Technical Field
The invention belongs to the technical field of materials, and particularly relates to a preparation method of porous nano hydroxyapatite sustained release gel.
background
Hydroxyapatite (HAP) has attracted extensive attention from biomaterials and medical professionals because its structure and composition are very close to human bone tissue. HAP is used as a bone filling material in orthopedics, stomatology and plastic surgery, is also used as a carrier for growth factors, drugs and the like, and shows good slow release performance. In order to meet different clinical requirements, researchers prepare HAPs in different shapes such as rods, dumbbells, spheres, tablets and the like. Spherical hydroxyapatite is currently receiving great attention due to its strong flowability, large specific surface area and high bulk density.
The method for preparing the hydroxyapatite microspheres is various, such as a hydrothermal method, an emulsion crosslinking method, a microwave method and a spray drying method. The emulsion crosslinking method is mainly used for preparing organic-inorganic composite hydroxyapatite microspheres, but the method has the problems that the microspheres are easy to agglomerate, the crosslinking agent is difficult to completely remove, and the like. The spray drying method has the advantages of simple operation, no need of adding toxic reagents, easy industrialization and the like, but also has the defects of irregular microspherical shape, wide particle size distribution and the like. The preparation method of the porous hydroxyapatite comprises a chemical foaming method, a pore-forming agent method, an organic foam impregnation method and an organic template method. When the porous hydroxyapatite is prepared by a chemical foaming method, the aperture and the porosity of the porous material are difficult to control, most of the pores of the porous material obtained by the method are closed, and the penetration rate of pores is poor. The porous hydroxyapatite prepared by the pore-forming agent method has low porosity and wide pore size distribution. In the process of drying and sintering, the organic foam impregnation method is easy to generate tiny cracks on the biological material, and the strength of the porous hydroxyapatite is reduced. The organic template method needs to select a proper surfactant, and the selected surfactant is possibly toxic and can be removed at high temperature under some conditions, so that the biological activity of the porous hydroxyapatite is reduced.
disclosure of Invention
In order to overcome the problems in the prior art, the invention provides a preparation method of porous nano hydroxyapatite sustained release gel, which is characterized by comprising the following steps:
The method comprises the following steps: adding the nano hydroxyapatite powder into water to prepare hydroxyapatite slurry with the content of 10-40% (w/v);
Step two: mixing the hydroxyapatite slurry, the pore-forming agent and the oleic acid in proportion, placing the mixture in a ball mill for ball milling for 6 to 24 hours, and obtaining uniform suspension after ball milling;
Step three: adding the suspension into an organic complexing agent, mixing in proportion, and then putting into a water bath kettle at 30-80 ℃ to be stirred and dissolved;
Step four: carrying out spray drying granulation on the uniformly dissolved suspension to obtain solidified microspheres;
Step five: carrying out high-temperature dewaxing treatment on the prepared solidified microspheres, and calcining at high temperature to prepare high-porosity porous nano hydroxyapatite microspheres;
Step six: embedding a drug into the high-porosity porous nano hydroxyapatite microspheres;
Step seven: respectively preparing mixed suspension liquid in which water-soluble alginate and high-porosity porous nano hydroxyapatite microspheres are uniformly dispersed, and preparing water-soluble calcium salt aqueous solution;
step eight: adding water-soluble calcium salt aqueous solution into the mixed suspension in a spray droplet mode, and soaking the mixed suspension into the water-soluble calcium salt aqueous solution for 10 minutes to 24 hours after the mixed suspension is gelatinized to obtain the porous nano-hydroxyapatite sustained-release gel.
Preferably, the weight ratio of the hydroxyapatite slurry to the pore-forming agent is 80-95: 20-5.
Preferably, the organic complexing agent is any combination of one or more of gelatin, Arabic gum, chitosan, sodium alginate, polylactic acid and natural cellulose.
preferably, the pore-forming agent is any one or any combination of carbon powder, graphite powder and acetylene black.
Preferably, the stirring speed of the water bath kettle is 200-.
preferably, the dewaxing temperature is 800-1500 ℃, and the dewaxing treatment time is 30-120 min.
preferably, the high-temperature calcination temperature is 1000-1500 ℃, and the calcination time is 45-180 min.
preferably, the spraying temperature is 250 ℃ to 500 ℃, the feeding speed is 10 to 30ml/min, and the spraying pressure is 0.05 to 0.1 MPa.
Preferably, the molar concentration of the water-soluble alginate in the mixed suspension is 0.01-10 mol/L.
preferably, the mass ratio of the high-porosity porous nano hydroxyapatite microspheres to the water-soluble alginate is 1: 10-10: 1.
Compared with the prior art, the invention has the beneficial effects that: the hydroxyapatite composite microsphere prepared by the method has uniform size distribution, the particle size distribution range of 10-100 mu m and the central particle size of 20-60 mu m. The organic phase is added in the mixing process, so that the suspension stability of the suspension can be effectively enhanced, the prepared microspheres are uniform in size distribution, have larger particle size than the microspheres prepared by the traditional spray drying method, and can be used as an inner support material of an injection; the microsphere has good sphericity, high porosity, enhanced injectability, accelerated drug metabolism, stable and effective drug concentration, and good drug release.
Drawings
FIG. 1 is a graph showing the cumulative release profiles of the drug over time in example 1.
FIG. 2 is a graph showing the cumulative release profiles of the drug over time in example 2.
FIG. 3 is a graph showing the cumulative release profiles of the drug over time in example 3.
Detailed Description
the method for preparing the porous nano-hydroxyapatite sustained-release gel proposed by the present invention will be described in more detail below with reference to schematic drawings, in which preferred embodiments of the present invention are shown, it being understood that a person skilled in the art may modify the invention described herein while still achieving the advantageous effects of the present invention. Accordingly, the following description should be construed as broadly as possible to those skilled in the art and not as limiting the invention.
example 1
The preparation method of the porous nano hydroxyapatite sustained release gel comprises the following steps:
The method comprises the following steps: adding the nano hydroxyapatite powder into water to prepare hydroxyapatite slurry with the content of 10-40% (w/v);
Step two: mixing hydroxyapatite slurry, a pore-forming agent and oleic acid in proportion, wherein the weight ratio of the hydroxyapatite slurry to the pore-forming agent is 80: 20. Ball-milling in a ball mill for 6-24 hours to obtain uniform suspension; the pore former is carbon powder.
Step three: adding the suspension into an organic complexing agent, mixing in proportion, and then putting into a water bath kettle at 80 ℃ to be stirred and dissolved; the organic complexing agent is the combination of gelatin, Arabic gum, chitosan and sodium alginate. The stirring speed of the water bath kettle is 600r/min, and the dissolving time is 5 h.
Step four: carrying out spray drying granulation on the uniformly dissolved suspension, wherein the spraying temperature is 250 ℃, the feeding speed is 10ml/min, and the spraying pressure is 0.05MPa, so as to obtain solidified microspheres;
Step five: carrying out high-temperature dewaxing treatment on the prepared solidified microspheres, wherein the dewaxing temperature is 800 ℃, and the dewaxing treatment time is 120 min; and then calcining the mixture at a high temperature of 1000 ℃ for 120min to prepare the high-porosity porous nano hydroxyapatite microspheres. In this embodiment 1, the particle size distribution range of the porous hydroxyapatite nanoparticles with high porosity is 20-75 μm, the central particle size is 20-60 μm, and the porosity is 78%.
step six: embedding a drug into the high-porosity porous nano hydroxyapatite microspheres;
Step seven: respectively preparing mixed suspension liquid in which water-soluble alginate and high-porosity porous nano hydroxyapatite microspheres are uniformly dispersed, and preparing water-soluble calcium salt aqueous solution;
Step eight: adding water-soluble calcium salt aqueous solution into the mixed suspension in a spray droplet mode, and soaking the mixed suspension into the water-soluble calcium salt aqueous solution for 10 minutes to 24 hours after the mixed suspension is gelatinized to obtain the porous nano-hydroxyapatite sustained-release gel. Through experiments, the curve diagram of the drug cumulative release degree of the porous nano hydroxyapatite sustained release gel at different time is shown in figure 1.
Example 2
The preparation method of the porous nano hydroxyapatite sustained release gel comprises the following steps:
The method comprises the following steps: adding the nano hydroxyapatite powder into water to prepare hydroxyapatite slurry with the content of 10-40% (w/v);
Step two: mixing hydroxyapatite slurry, a pore-forming agent and oleic acid in proportion, wherein the weight ratio of the hydroxyapatite slurry to the pore-forming agent is 85: 15. Ball-milling in a ball mill for 6-24 hours to obtain uniform suspension; the pore former is carbon powder.
Step three: adding the suspension into an organic complexing agent, mixing in proportion, and then putting into a water bath kettle at 50 ℃ to be stirred and dissolved; the organic complexing agent is the combination of gelatin, Arabic gum, chitosan and sodium alginate. The stirring speed of the water bath kettle is 250r/min, and the dissolving time is 5 h.
step four: carrying out spray drying granulation on the uniformly dissolved suspension, wherein the spraying temperature is 250 ℃, the feeding speed is 10ml/min, and the spraying pressure is 0.05MPa, so as to obtain solidified microspheres;
step five: carrying out high-temperature dewaxing treatment on the prepared solidified microspheres, wherein the dewaxing temperature is 1500 ℃, and the dewaxing treatment time is 60 min; and then calcining the mixture at a high temperature of 1000 ℃ for 180min to prepare the high-porosity porous nano hydroxyapatite microspheres. In this embodiment 2, the particle size distribution range of the porous hydroxyapatite nanoparticles with high porosity is 60-85 μm, the central particle size is 20-60 μm, and the porosity is 78%.
Step six: embedding a drug into the high-porosity porous nano hydroxyapatite microspheres;
Step seven: respectively preparing mixed suspension liquid in which water-soluble alginate and high-porosity porous nano hydroxyapatite microspheres are uniformly dispersed, and preparing water-soluble calcium salt aqueous solution;
Step eight: adding water-soluble calcium salt aqueous solution into the mixed suspension in a spray droplet mode, and soaking the mixed suspension into the water-soluble calcium salt aqueous solution for 10 minutes to 24 hours after the mixed suspension is gelatinized to obtain the porous nano-hydroxyapatite sustained-release gel. Through experiments, the curve diagram of the drug cumulative release degree of the porous nano hydroxyapatite sustained release gel at different time is shown in figure 2.
Example 3
The preparation method of the porous nano hydroxyapatite sustained release gel comprises the following steps:
The method comprises the following steps: adding the nano hydroxyapatite powder into water to prepare hydroxyapatite slurry with the content of 10-40% (w/v);
Step two: mixing hydroxyapatite slurry, a pore-forming agent and oleic acid in proportion, wherein the weight ratio of the hydroxyapatite slurry to the pore-forming agent is 95: 5. Ball-milling in a ball mill for 6-24 hours to obtain uniform suspension; the pore former is carbon powder.
Step three: adding the suspension into an organic complexing agent, mixing in proportion, and then putting into a water bath kettle at 50 ℃ to be stirred and dissolved; the organic complexing agent is the combination of gelatin, Arabic gum, chitosan and sodium alginate. The stirring speed of the water bath kettle is 250r/min, and the dissolving time is 5 h.
Step four: carrying out spray drying granulation on the uniformly dissolved suspension, wherein the spraying temperature is 250 ℃, the feeding speed is 10ml/min, and the spraying pressure is 0.1MPa, so as to obtain solidified microspheres;
Step five: carrying out high-temperature dewaxing treatment on the prepared solidified microspheres, wherein the dewaxing temperature is 1500 ℃, and the dewaxing treatment time is 60 min; and then calcining the mixture at a high temperature of 1000 ℃ for 180min to prepare the high-porosity porous nano hydroxyapatite microspheres. In this embodiment 3, the particle size distribution range of the porous hydroxyapatite nanoparticles with high porosity is 50-85 μm, the central particle size is 20-60 μm, and the porosity is 89%. The high-porosity porous nano hydroxyapatite microspheres prepared by the embodiment have high porosity, almost complete penetration and moderate mechanical strength.
step six: embedding a drug into the high-porosity porous nano hydroxyapatite microspheres;
Step seven: respectively preparing mixed suspension liquid in which water-soluble alginate and high-porosity porous nano hydroxyapatite microspheres are uniformly dispersed, and preparing water-soluble calcium salt aqueous solution;
step eight: adding water-soluble calcium salt aqueous solution into the mixed suspension in a spray droplet mode, and soaking the mixed suspension into the water-soluble calcium salt aqueous solution for 10 minutes to 24 hours after the mixed suspension is gelatinized to obtain the porous nano-hydroxyapatite sustained-release gel. Experiments show that the curve diagram of the drug cumulative release degree of the porous nano hydroxyapatite sustained release gel at different time is shown in figure 3.
the above description is only a preferred embodiment of the present invention, and does not limit the present invention in any way. It will be understood by those skilled in the art that various changes, substitutions and alterations can be made herein without departing from the spirit and scope of the invention as defined by the appended claims.
Claims (10)
1. A preparation method of porous nano hydroxyapatite sustained release gel is characterized by comprising the following steps:
The method comprises the following steps: adding the nano hydroxyapatite powder into water to prepare hydroxyapatite slurry with the content of 10-40% (w/v);
step two: mixing the hydroxyapatite slurry, the pore-forming agent and the oleic acid in proportion, placing the mixture in a ball mill for ball milling for 6 to 24 hours, and obtaining uniform suspension after ball milling;
step three: adding the suspension into an organic complexing agent, mixing in proportion, and then putting into a water bath kettle at 30-80 ℃ to be stirred and dissolved;
step four: carrying out spray drying granulation on the uniformly dissolved suspension to obtain solidified microspheres;
step five: carrying out high-temperature dewaxing treatment on the prepared solidified microspheres, and calcining at high temperature to prepare high-porosity porous nano hydroxyapatite microspheres;
step six: embedding a drug into the high-porosity porous nano hydroxyapatite microspheres;
step seven: respectively preparing mixed suspension liquid in which water-soluble alginate and high-porosity porous nano hydroxyapatite microspheres are uniformly dispersed, and preparing water-soluble calcium salt aqueous solution;
Step eight: adding water-soluble calcium salt aqueous solution into the mixed suspension in a spray droplet mode, and soaking the mixed suspension into the water-soluble calcium salt aqueous solution for 10 minutes to 24 hours after the mixed suspension is gelatinized to obtain the porous nano-hydroxyapatite sustained-release gel.
2. the preparation method of the porous nano hydroxyapatite sustained release gel according to claim 1, characterized in that the weight ratio of the hydroxyapatite slurry to the pore forming agent is 80-95: 20-5.
3. The preparation method of the porous nano hydroxyapatite sustained release gel according to claim 1, wherein the organic complexing agent is one or more of gelatin, acacia, chitosan, sodium alginate, polylactic acid and natural cellulose.
4. The preparation method of the porous nano hydroxyapatite sustained release gel according to claim 1, wherein the pore-forming agent is any one or any combination of carbon powder, graphite powder and acetylene black.
5. the method for preparing the porous nano hydroxyapatite sustained release gel according to claim 1, characterized in that the stirring speed of the water bath is 200-.
6. The preparation method of the porous nano hydroxyapatite sustained release gel according to claim 1, wherein the dewaxing temperature is 800 to 1500 ℃, and the dewaxing treatment time is 30 to 120 min.
7. The preparation method of the porous nano hydroxyapatite sustained release gel according to claim 1, wherein the high temperature calcination temperature is 1000 to 1500 ℃, and the calcination time is 45 to 180 min.
8. The method for preparing the porous nano hydroxyapatite sustained release gel according to claim 1, wherein the spraying temperature is 250 ℃ and 500 ℃, the feeding speed is 10-30ml/min, and the spraying pressure is 0.05-0.1 MPa.
9. the preparation method of the porous nano hydroxyapatite sustained release gel according to claim 1, wherein the molar concentration of the water-soluble alginate in the mixed suspension is 0.01 to 10 mol/l.
10. The preparation method of the porous nano hydroxyapatite sustained release gel according to claim 1, wherein the mass ratio of the high-porosity porous nano hydroxyapatite microspheres to the water-soluble alginate is 1: 10-10: 1.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE20195545A BE1027074B1 (en) | 2018-12-10 | 2019-08-20 | Process for preparing a porous nanohydroxyapatite sustained release gel |
| NL2023785A NL2023785B1 (en) | 2018-12-10 | 2019-09-06 | Preparation Method for Porous Nano-hydroxyapatite Sustained Release Gel |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201811502474.0A CN109529110A (en) | 2018-12-10 | 2018-12-10 | Porous nano hydroxyapatite sustained-release gel preparation method |
| CN2018115024740 | 2018-12-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110538346A true CN110538346A (en) | 2019-12-06 |
| CN110538346B CN110538346B (en) | 2022-07-15 |
Family
ID=65853264
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811502474.0A Pending CN109529110A (en) | 2018-12-10 | 2018-12-10 | Porous nano hydroxyapatite sustained-release gel preparation method |
| CN201910323669.7A Active CN110538346B (en) | 2018-12-10 | 2019-04-22 | Preparation method of porous nano hydroxyapatite sustained-release gel |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201811502474.0A Pending CN109529110A (en) | 2018-12-10 | 2018-12-10 | Porous nano hydroxyapatite sustained-release gel preparation method |
Country Status (3)
| Country | Link |
|---|---|
| CN (2) | CN109529110A (en) |
| BE (1) | BE1027074B1 (en) |
| NL (1) | NL2023785B1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112500097A (en) * | 2020-12-28 | 2021-03-16 | 湖北工业大学 | Self-repairing steel slag-slag concrete and preparation method thereof |
| CN115124753A (en) * | 2022-07-14 | 2022-09-30 | 元柔科技(北京)有限公司 | Porous flexible material and pressure sensor prepared from same |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1027375B1 (en) * | 2018-12-10 | 2021-01-26 | Shanghai Moyang Biotechnology Co Ltd | High porosity porous nanohydroxyapatite microsphere and its preparation process |
| CN109529111A (en) * | 2018-12-12 | 2019-03-29 | 上海摩漾生物科技有限公司 | High porosity porous nano hydroxyapatite micro-sphere and preparation method thereof |
| CN110182779A (en) * | 2019-05-07 | 2019-08-30 | 湖南雅城新材料有限公司 | The preparation method of ferric phosphate duct material |
| CN112028044A (en) * | 2020-08-11 | 2020-12-04 | 浙江拜尔克生物科技有限公司 | Apatite microcarrier and preparation method and application thereof |
| CN115926198A (en) * | 2021-09-23 | 2023-04-07 | 四川大学 | Injectable tissue regeneration type filler and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101343054A (en) * | 2008-08-19 | 2009-01-14 | 华南理工大学 | Preparation method of hydroxyapatite microsphere |
| CN101361715A (en) * | 2008-09-11 | 2009-02-11 | 天津大学 | Preparation method of drug-carrying hydroxylapatite microspheres and bone cement composite porous microspheres |
| CN105079876A (en) * | 2015-08-31 | 2015-11-25 | 华南理工大学 | Porous drug-loaded composite microsphere support material as well as preparation method and application thereof |
| CN106458585A (en) * | 2014-03-03 | 2017-02-22 | 百维科技有限责任公司 | Spherical porous hydroxyapatite sorbent and methods thereof |
| CN106565974A (en) * | 2016-10-20 | 2017-04-19 | 中国科学院上海硅酸盐研究所 | Alginate/hydroxyapatite super-long nanowire composite hydrogel |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH03249911A (en) * | 1990-02-26 | 1991-11-07 | Central Glass Co Ltd | Ceramic filter for removing protein |
-
2018
- 2018-12-10 CN CN201811502474.0A patent/CN109529110A/en active Pending
-
2019
- 2019-04-22 CN CN201910323669.7A patent/CN110538346B/en active Active
- 2019-08-20 BE BE20195545A patent/BE1027074B1/en active IP Right Grant
- 2019-09-06 NL NL2023785A patent/NL2023785B1/en active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101343054A (en) * | 2008-08-19 | 2009-01-14 | 华南理工大学 | Preparation method of hydroxyapatite microsphere |
| CN101361715A (en) * | 2008-09-11 | 2009-02-11 | 天津大学 | Preparation method of drug-carrying hydroxylapatite microspheres and bone cement composite porous microspheres |
| CN106458585A (en) * | 2014-03-03 | 2017-02-22 | 百维科技有限责任公司 | Spherical porous hydroxyapatite sorbent and methods thereof |
| CN105079876A (en) * | 2015-08-31 | 2015-11-25 | 华南理工大学 | Porous drug-loaded composite microsphere support material as well as preparation method and application thereof |
| CN106565974A (en) * | 2016-10-20 | 2017-04-19 | 中国科学院上海硅酸盐研究所 | Alginate/hydroxyapatite super-long nanowire composite hydrogel |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112500097A (en) * | 2020-12-28 | 2021-03-16 | 湖北工业大学 | Self-repairing steel slag-slag concrete and preparation method thereof |
| CN112500097B (en) * | 2020-12-28 | 2022-06-14 | 湖北工业大学 | Self-repairing steel slag-slag concrete and preparation method thereof |
| CN115124753A (en) * | 2022-07-14 | 2022-09-30 | 元柔科技(北京)有限公司 | Porous flexible material and pressure sensor prepared from same |
| CN115124753B (en) * | 2022-07-14 | 2023-07-25 | 元柔科技(北京)有限公司 | Porous flexible material and pressure sensor prepared from same |
Also Published As
| Publication number | Publication date |
|---|---|
| BE1027074B1 (en) | 2020-09-16 |
| CN110538346B (en) | 2022-07-15 |
| CN109529110A (en) | 2019-03-29 |
| NL2023785B1 (en) | 2020-11-18 |
| NL2023785A (en) | 2020-10-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110538346B (en) | Preparation method of porous nano hydroxyapatite sustained-release gel | |
| CN101361715B (en) | Preparation method of drug-carrying hydroxylapatite microspheres and bone cement composite porous microspheres | |
| Perez et al. | Porous hydroxyapatite and gelatin/hydroxyapatite microspheres obtained by calcium phosphate cement emulsion | |
| CN104548213B (en) | Porous spherical calcium phosphate filling material and preparing method thereof | |
| CN110538347A (en) | High-porosity porous nano hydroxyapatite microspheres and preparation method thereof | |
| US11077225B2 (en) | Hollow porous spherical particle artificial bone as well as preparation method and application thereof | |
| CN105031718A (en) | Bone repair porous compound scaffold based on 3D (three-dimensional)-Bioplotter printing technology and preparation method thereof | |
| CN107789332B (en) | Calcium carbonate/calcium alginate composite microspheres capable of adjusting drug release rate and prepared based on double-aqueous-phase biomineralization technology | |
| KR100892906B1 (en) | Porous calcium phosphate ceramic and method for producing same | |
| CN113101410B (en) | Tricalcium phosphate support with uniform mesopore and three-dimensional communicated hierarchical pore structure as well as preparation method and application of tricalcium phosphate support | |
| AU2012258092B2 (en) | Process for producing inorganic particulate material | |
| CN110396205B (en) | Pickering high internal phase emulsion, 3D printing porous scaffold material and preparation method thereof | |
| CN106512103A (en) | Preparation method of porous structural ceramic material | |
| CN105056298A (en) | Porous calcium phosphate microsphere material with surface big holes and preparation method and application of porous calcium phosphate microsphere material | |
| CN110694109A (en) | Calcium phosphate bone cement scaffold compounded with drug-loaded polymer microspheres and application | |
| EP3157861B1 (en) | Method for producing porous calcium deficient hydroxyapatite granules | |
| CN110882419A (en) | Self-curing calcium phosphate bone cement scaffold and preparation method and application thereof | |
| CN105963789A (en) | Method for preparing bone tissue engineering scaffold material | |
| CN112957522B (en) | Rigidity-adjustable porous liquid metal bone tissue engineering scaffold and preparation method thereof | |
| CN112028620B (en) | Porous hydroxyapatite bioactive material and preparation method and application thereof | |
| CN112876281B (en) | Preparation method and application of biological ceramic support with hollow microsphere surface micro-nano structure | |
| Liu et al. | A Quick and Convenient Route to Prepare Hydroxyapatite Porous Microspheres | |
| BE1027375B1 (en) | High porosity porous nanohydroxyapatite microsphere and its preparation process | |
| CN109701082B (en) | Preparation method and application of hydroxyapatite-titanium hydroxide composite powder | |
| CN112891622A (en) | Porous calcium-magnesium dual-phase ceramic microsphere and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CB02 | Change of applicant information |
Address after: 201114 Room 201, 206-210, building 3, No. 999, Jiangyue Road, Minhang District, Shanghai Applicant after: SHANGHAI MOYANG BIOLOGICAL TECHNOLOGY Co.,Ltd. Address before: Room 205, Building No. 999, Jiangyue Road, Minhang District, Shanghai, 20114 Applicant before: SHANGHAI MOYANG BIOLOGICAL TECHNOLOGY Co.,Ltd. |
|
| CB02 | Change of applicant information | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |